Cellebrite DI (CLBT) Payables (2020 - 2025)

Cellebrite DI (CLBT) has reported Payables for 6 consecutive years, with $16.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Payables fell 73.42% year-over-year to $16.8 million; the TTM figure through Dec 2025 stood at $16.8 million (down 73.42% YoY), while the FY2025 annual figure was $16.8 million, down 73.42% from the prior year.
• Payables came in at $16.8 million for Q4 2025 at Cellebrite DI, up from $11.1 million in the prior quarter.
• The five-year high for Payables was $63.3 million in Q4 2024, with the low at $3.8 million in Q2 2022.
• Average Payables over 5 years is $15.2 million, with a median of $8.6 million recorded in 2022.
• Across the five-year window, Payables surged 376.15% in 2022 and plunged 73.42% in 2025, its largest moves.
• Year by year, Payables stood at $9.5 million in 2021, then soared by 376.15% to $45.5 million in 2022, then dropped by 1.34% to $44.8 million in 2023, then jumped by 41.22% to $63.3 million in 2024, then slumped by 73.42% to $16.8 million in 2025.
• According to Business Quant data, Payables over the past three periods registered $16.8 million, $11.1 million, and $10.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.